INTERNATIONAL PATENT: CARDIOMIX S.R.L. FILES APPLICATION FOR "ANTI NAV1.5 CHANNEL AUTOANTIBODIES AS BIOMARKERS FOR PREDICTING THE RISK OF CARDIAC ARRHYTHMIA AND SUDDEN CARDIAC DEATH IN CANCER PATIENTS"

GENEVA, Nov. 10 -- CARDIOMIX S.R.L. (Via Arrigo Boito, 820121 Milan) filed a patent application (PCT/EP2025/062074) for "ANTI NAV1.5 CHANNEL AUTOANTIBODIES AS BIOMARKERS FOR PREDICTING THE RISK OF CARDIAC ARRHYTHMIA AND SUDDEN CARDIAC DEATH IN CANCER PATIENTS" on May 02, 2025. With publication no. WO/2025/229182, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANASTASIA, Luigi (c/o CARDIOMIX S.r.l.Via Arrigo Boito, 820121 Milan), TARANTINO, Adriana (c/o CARDIOMIX S.r.l.Via Arrigo Boito, 820121 Milan), CICONTE, Giuseppe (c...